businessLIVE
Rocket stock 4DMedical in retail investors vs hedge funds battle
Retail investors and hedge funds clash over 4DMedical, a stock that hedge funds favour shorting.
Key points
- 4DMedical has delivered more shareholder returns than many companies in the major sharemarket index.
- Hedge funds are a favourite to short 4DMedical, according to the article.
- Institutions and retail investors disagree about whether 4DMedical is appropriately governed.
Why it matters. Investors are divided over 4DMedical's governance and short selling, the article says, so the stock is a poor guide to how the market values businesses.
4DMedical has delivered more shareholder returns than many companies in the major Australian sharemarket index, yet it is a favourite among hedge funds to short. Institutions and retail investors disagree about whether the medical technology firm is appropriately governed, the article says. The article argues the stock would be a poor place to start for anyone trying to understand how the sharemarket values businesses and allocates capital.
Latest updates
Rocket stock 4DMedical in retail investors vs hedge funds battle
To understand recent trading in rocket stock 4DMedical, you need to consider how big funds vote. If you’re trying to understand how the Australian sharemarket values businesses and allocates capital across the global economy, 4DMedical would not be a good place to start. It’s a company that has delivered more than many, in terms of shareholder returns in the major sharemarket index but at the same time, it’s a favourite among hedge funds to short while institutions and retail investors are in disagreement about whether it’s appropriately governed. Subscribe to gift this article Gift articles to anyone you choose each month when you subscribe. Fetching latest articles.